WAT Straddle Strategy
WAT (Waters Corporation), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research.
WAT (Waters Corporation) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $21.83B, a trailing P/E of 61.24, a beta of 1.14 versus the broader market, a 52-week range of 275.05-414.15, average daily share volume of 1.1M, a public-listing history dating back to 1995, approximately 8K full-time employees. These structural characteristics shape how WAT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.14 places WAT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 61.24 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a straddle on WAT?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current WAT snapshot
As of May 15, 2026, spot at $331.27, ATM IV 34.70%, IV rank 28.56%, expected move 9.95%. The straddle on WAT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on WAT specifically: WAT IV at 34.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a WAT straddle, with a market-implied 1-standard-deviation move of approximately 9.95% (roughly $32.96 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated WAT expiries trade a higher absolute premium for lower per-day decay. Position sizing on WAT should anchor to the underlying notional of $331.27 per share and to the trader's directional view on WAT stock.
WAT straddle setup
The WAT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With WAT near $331.27, the first option leg uses a $330.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed WAT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 WAT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $330.00 | $15.05 |
| Buy 1 | Put | $330.00 | $13.00 |
WAT straddle risk and reward
- Net Premium / Debit
- -$2,805.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$2,766.04
- Breakeven(s)
- $301.95, $358.05
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
WAT straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on WAT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$30,194.00 |
| $73.25 | -77.9% | +$22,869.55 |
| $146.50 | -55.8% | +$15,545.10 |
| $219.74 | -33.7% | +$8,220.64 |
| $292.99 | -11.6% | +$896.19 |
| $366.23 | +10.6% | +$818.26 |
| $439.48 | +32.7% | +$8,142.71 |
| $512.72 | +54.8% | +$15,467.17 |
| $585.97 | +76.9% | +$22,791.62 |
| $659.21 | +99.0% | +$30,116.07 |
When traders use straddle on WAT
Straddles on WAT are pure-volatility plays that profit from large moves in either direction; traders typically buy WAT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
WAT thesis for this straddle
The market-implied 1-standard-deviation range for WAT extends from approximately $298.31 on the downside to $364.23 on the upside. A WAT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current WAT IV rank near 28.56% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on WAT at 34.70%. As a Healthcare name, WAT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to WAT-specific events.
WAT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. WAT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move WAT alongside the broader basket even when WAT-specific fundamentals are unchanged. Always rebuild the position from current WAT chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on WAT?
- A straddle on WAT is the straddle strategy applied to WAT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With WAT stock trading near $331.27, the strikes shown on this page are snapped to the nearest listed WAT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are WAT straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the WAT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 34.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$2,766.04 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a WAT straddle?
- The breakeven for the WAT straddle priced on this page is roughly $301.95 and $358.05 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current WAT market-implied 1-standard-deviation expected move is approximately 9.95%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on WAT?
- Straddles on WAT are pure-volatility plays that profit from large moves in either direction; traders typically buy WAT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current WAT implied volatility affect this straddle?
- WAT ATM IV is at 34.70% with IV rank near 28.56%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.